
DMRA vs RARE
$DMRA vs $RARE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DMRA vs RARE: the quick read
- ·RARE is the larger company by market cap ($1.43B vs $1.39B).
- ·RARE has been more active on our scanner (250 vs 64 alerts in 30 days).
- ·DMRA has the smaller float (61.5M vs 98.0M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·RARE draws far more of our scanner's attention, 250 unusual-volume alerts in 30 days against 64, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·DMRA is the one in play today, trading about 7.5x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DMRA and RARE on TheDesperateTrader.
- Is DMRA or RARE the better stock?
- "Better" depends on your goal, and these two are not alike. RARE is the larger company by market cap ($1.43B vs $1.39B). RARE has been more active on our scanner (250 vs 64 alerts in 30 days). DMRA has the smaller float (61.5M vs 98.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DMRA and RARE?
- The differences that matter: they are not in the same business - DMRA is pharmaceutical preparations and RARE is pharmaceutical preparations; they are similar in size ($1.39B vs $1.43B); they trade at very different share prices ($22.19 vs $14.52); DMRA sits at 31% of its 52-week range against 7% for RARE; our scanner flagged DMRA 64 times in the last 30 days against 250 for RARE. Everything above is measured from the latest completed session and SEC filings.
- Which of DMRA and RARE is more active right now?
- Right now DMRA is at about 7.5x its normal volume and RARE is at about 3.1x, so DMRA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DMRA or RARE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DMRA and RARE comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.